211 related articles for article (PubMed ID: 26556040)
1. Factors contributing to the treatment duration of diphenylcyclopropenone immunotherapy for periungual warts.
Park HK; Kim JS
Dermatol Ther; 2016; 29(2):114-9. PubMed ID: 26556040
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cure rates and durations of treatment with diphenylcyclopropenone immunotherapy for warts in children/adolescents and adults.
Kang HS; Lee MW; Paek JO; Yu HJ; Kim JS
Int J Dermatol; 2014 Oct; 53(10):1293-8. PubMed ID: 24697739
[TBL] [Abstract][Full Text] [Related]
3. Topical immunotherapy with diphenylcyclopropenone is effective and preferred in the treatment of periungual warts.
Choi Y; Kim DH; Jin SY; Lee AY; Lee SH
Ann Dermatol; 2013 Nov; 25(4):434-9. PubMed ID: 24371390
[TBL] [Abstract][Full Text] [Related]
4. Investigations of the efficacy of diphenylcyclopropenone immunotherapy for the treatment of warts.
Suh DW; Lew BL; Sim WY
Int J Dermatol; 2014 Dec; 53(12):e567-71. PubMed ID: 25427069
[TBL] [Abstract][Full Text] [Related]
5. Treatment of disseminated facial warts through contact immunotherapy with diphenylcyclopropenone (DPCP).
Aghaei S
Dermatol Online J; 2006 Feb; 12(2):10. PubMed ID: 16638403
[TBL] [Abstract][Full Text] [Related]
6. Clinical Efficacy of Diphenylcyclopropenone Immunotherapy as Monotherapy for Multiple Viral Warts.
Park JY; Park BW; Cho EB; Park EJ; Kim KH; Kim KJ
J Cutan Med Surg; 2018; 22(3):285-289. PubMed ID: 29528750
[TBL] [Abstract][Full Text] [Related]
7. Intralesional Antigen Immunotherapy in the Treatment of Periungual Warts.
Nofal A; Alakad R; Fouda I; Fawzy MM
J Cutan Med Surg; 2021; 25(3):286-292. PubMed ID: 33504211
[TBL] [Abstract][Full Text] [Related]
8. What factors affect the duration of treatment with diphenylcyclopropenone immunotherapy for common warts?
Seo HM; Park HK; Kim TL; Kim JS
Dermatol Ther; 2018 Nov; 31(6):e12740. PubMed ID: 30203625
[No Abstract] [Full Text] [Related]
9. The use of diphenylcyclopropenone in the treatment of recalcitrant warts.
Upitis JA; Krol A
J Cutan Med Surg; 2002; 6(3):214-7. PubMed ID: 11951129
[TBL] [Abstract][Full Text] [Related]
10. Enhanced efficacy of photodynamic therapy with methyl 5-aminolevulinic acid in recalcitrant periungual warts after ablative carbon dioxide fractional laser: a pilot study.
Yoo KH; Kim BJ; Kim MN
Dermatol Surg; 2009 Dec; 35(12):1927-32. PubMed ID: 19681999
[TBL] [Abstract][Full Text] [Related]
11. Contact immunotherapy of resistant warts.
Naylor MF; Neldner KH; Yarbrough GK; Rosio TJ; Iriondo M; Yeary J
J Am Acad Dermatol; 1988 Oct; 19(4):679-83. PubMed ID: 3053802
[TBL] [Abstract][Full Text] [Related]
12. Diphencyprone in the management of refractory palmoplantar and periungual warts: an open study.
Rampen FH; Steijlen PM
Dermatology; 1996; 193(3):236-8. PubMed ID: 8944347
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of periungual warts with diluted bleomycin using translesional multipuncture technique: a pilot prospective study.
AlGhamdi KM; Khurram H
Dermatol Surg; 2011 Apr; 37(4):486-92. PubMed ID: 21414076
[TBL] [Abstract][Full Text] [Related]
14. [Pharma-clinics. How I treat ... periungual warts].
Lambert J; Richert B; de la Brassinne M
Rev Med Liege; 1999 Aug; 54(8):646-52. PubMed ID: 10548889
[TBL] [Abstract][Full Text] [Related]
15. Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: Retrospective analysis of 159 cases.
Choe SJ; Lee S; Pi LQ; Keum DI; Lee CH; Kim BJ; Lee WS
J Am Acad Dermatol; 2018 Mar; 78(3):515-521.e4. PubMed ID: 29108907
[TBL] [Abstract][Full Text] [Related]
16. Don't excise--exorcise. Treatment for subungual and periungual warts.
Litt JZ
Cutis; 1978 Dec; 22(6):673-6. PubMed ID: 720133
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
Durdu M; Özcan D; Baba M; Seçkin D
J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
[TBL] [Abstract][Full Text] [Related]
18. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
Galadari I; Rubaie S; Alkaabi J; Galadari H
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunohistochemical responses of plantar warts to topical immunotherapy with diphenylcyclopropenone.
van der Steen P; van de Kerkhof P; der Kinderen D; van Vlijmen I; Happle R
J Dermatol; 1991 Jun; 18(6):330-3. PubMed ID: 1939862
[TBL] [Abstract][Full Text] [Related]
20. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
Aghaei S
BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
